Euda seeks Nasdaq listing via spac to gain better opportunities in healthcare market

Samantha Chiew
Samantha Chiew6/15/2022 02:22 PM GMT+08  • 8 min read
Euda seeks Nasdaq listing via spac to gain better opportunities in healthcare market
Chen: One of the key reasons for us listing, aside from getting funding, is to obtain accreditation and transparency as a listed healthcare company. Photo: Albert Chua/ The Edge Singapore
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Singapore-based healthtech company Euda Health is aware that for start-up healthcare companies to gain growth traction within the rather traditional industry, it can be tough, especially when trust is only given to those that have been in the industry for a long time.

Founder and CEO Dr Kelvin Chen says this is the reason why it has decided to take the company public, after having been around for some five years. He tells The Edge Singapore: “One of the key reasons for us listing, aside from getting funding, is to obtain accreditation and transparency as a listed healthcare company.”

Chen adds that contracts given within the healthcare industry always favour those that have an established reputation and have been around for very long. Many companies are wary of awarding contracts to start-ups, as there is a fear that these companies will not be able to continue the service after being awarded the contract.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now